A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

December 4, 2020

Study Completion Date

December 4, 2020

Conditions

Sever Aplastic Anaemia

Interventions

DRUG

Hetrombopag Olamine Tablet

Trial Locations (1)

The First Bethune Hospital of Jilin University, Changchun

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05088642 - A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects | Biotech Hunter | Biotech Hunter